Literature DB >> 11716142

Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus.

A Olariu1, M H Tran, K Yamada, M Mizuno, V Hefco, T Nabeshima.   

Abstract

In the present study we found that chronic infusion of beta-amyloid fragment (25-35) at nanomolar concentration into rat cerebral ventricle impairs learning and memory. At a concentration of 3 nmol/day but not 0.3 nmol/day, beta-amyloid significantly reduced the spontaneous alternation behavior and the memory performance in the water maze and multiple passive avoidance tests. A significant increase in anxiety was also found in the animals infused with 3 nmol/day beta-amyloid fragment. Memory deficits and the increased emotionality were correlated with a decreased nicotine-evoked acetylcholine release from the frontal cortex/hippocampus, as assessed by microdialysis, in freely moving rats. The amyloid fragment infused either at pico- or nanomolar concentrations reduced the affinity of [3H] phorbol dibutyrate binding, an index of activated protein kinase C (PKC), and increased the total number of binding sites in the hippocampal particulate fraction. Our results suggest that the amnesic and anxiogenic effects of chronic infusion of beta-amyloid (25-35) are related to the decreased acetylcholine release and reduced PKC activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716142     DOI: 10.1007/s007020170025

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  19 in total

1.  Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats.

Authors:  Yu-Fang Cheng; Chuang Wang; Huan-Bing Lin; Yun-Feng Li; Ying Huang; Jiang-Ping Xu; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2010-07-17       Impact factor: 4.530

2.  Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze.

Authors:  M Yu Stepanichev; Yu V Moiseeva; N A Lazareva; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2005-06

3.  Studies of the effects of central administration of beta-amyloid peptide (25-35): pathomorphological changes in the Hippocampus and impairment of spatial memory.

Authors:  M Yu Stepanichev; I M Zdobnova; I I Zarubenko; N A Lazareva; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2006-01

Review 4.  Brain histamine modulates recognition memory: possible implications in major cognitive disorders.

Authors:  Gustavo Provensi; Alessia Costa; Ivan Izquierdo; Patrizio Blandina; Maria Beatrice Passani
Journal:  Br J Pharmacol       Date:  2018-09-22       Impact factor: 8.739

5.  Methanolic extract of Piper nigrum fruits improves memory impairment by decreasing brain oxidative stress in amyloid beta(1-42) rat model of Alzheimer's disease.

Authors:  Lucian Hritcu; Jaurès A Noumedem; Oana Cioanca; Monica Hancianu; Victor Kuete; Marius Mihasan
Journal:  Cell Mol Neurobiol       Date:  2014-01-19       Impact factor: 5.046

6.  The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.

Authors:  J Meunier; J Ieni; T Maurice
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

7.  Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.

Authors:  Giuseppe D'Agostino; Roberto Russo; Carmen Avagliano; Claudia Cristiano; Rosaria Meli; Antonio Calignano
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

8.  The modulatory role of phloretin in Aβ25-35 induced sporadic Alzheimer's disease in rat model.

Authors:  Priya J Ghumatkar; Sachin P Patil; Vaibhavi Peshattiwar; Tushara Vijaykumar; Vikas Dighe; Geeta Vanage; Sadhana Sathaye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-28       Impact factor: 3.000

9.  Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Authors:  Valentine Lahmy; Johann Meunier; Susanna Malmström; Gaelle Naert; Laurent Givalois; Seung Hyun Kim; Vanessa Villard; Alexandre Vamvakides; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2013-03-14       Impact factor: 7.853

Review 10.  Septohippocampal acetylcholine: involved in but not necessary for learning and memory?

Authors:  Marise B Parent; Mark G Baxter
Journal:  Learn Mem       Date:  2004 Jan-Feb       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.